SYNTHACE LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +14.8%

  £2,506,720 → £2,877,780

• Cash

  -89%

  £3,998,475 → £439,512

  lowest in 6 filed years

• Net assets

  -16,512.6%

  £50,794 → -£8,336,591

• Employees

  -14.7%

  75 → 64

• Operating profit

  +17.9%

  -£11,569,963 → -£9,498,614

• Profit before tax

  +11.5%

  -£11,614,207 → -£10,284,161

• Wages

  -13.3%

  £7,009,361 → £6,079,449

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Ensors

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”

Group structure

1. SYNTHACE LIMITED · parent
   1. Synthace Inc 100% · USA

Significant events

• “During the year, the Group transitioned to a focus on Drug Discovery as its main market, due to the fully proven, high level of efficacy observed for Synthace software and services in this area.”
• “On 9 August 2025, a deed of variation was signed which converted all convertible loan notes into a new class of Preferred Shares.”
• “On 21 October 2025, Synthace Limited entered into an agreement to surrender its old leased premises and enter into a new lease agreement.”
• “On 3 July 2025, Synthace Limited signed a term sheet to issue 69,124,420 ordinary series "AA" shares at \u00a30.0434 per share, for total consideration of \u00a33,000,000.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

20

last 12 months

Capital events

10

last 24 months

Officers appointed

1

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.